ORAGENICS, INC. Inventory, Work in Process, Gross
ORAGENICS, INC. (OGEN) had Inventory, Work in Process, Gross of $58.60 thousand as of 2011-12-31, per its 10-K filed 2013-03-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2013-03-26
- 2011-12-31: Inventory, Work in Process, Gross $58.60K.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2011-12-31 | $58.60K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |